Natural products drug discovery research in India: Status and appraisal

Indian Journal of Experimental Biology

Volumn 48, Issue 3, 2010, Pages 199-207

  Bhutani, Kamlesh K ^a   Gohil, Vikrantsinh M ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anti diabetic; Anti malaria; Anti obestiy; Cardio protection; Natural products

Indexed keywords

BIOLOGICAL PRODUCT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DEVELOPMENT; DRUG SCREENING; HUMAN; INDIA; MEDICAL RESEARCH; METHODOLOGY;

ANIMALS; BIOLOGICAL PRODUCTS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; INDIA;

EID: 77954254340     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Harvey A L, Natural products in drug discovery, Drug Discov Today, 13 (2008) 894.
2. Butler M S, Natural products to drugs: natural product-derived compounds in clinical trials, Nat Prod Rep, 25 (2008) 475.
3. Patwardhan B & Mashelkar R A, Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?, Drug Discov Today, 14 (2009) 804.
4. Alexander J, 38 ayurvedic formulations identified for 8 disease conditions under Golden Triangle scheme. http://www.pharmabiz.com/article/detnews.asp?articleid=51493§ionid=
5. Moore R J, Owens D M, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G & Balkwill F, Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis, Nat Med, 5 (1999) 828.
6. Hotamisligil G S, Murray D L, Choy L N & Spiegelman B M, Tumor necrosis factor alpha inhibits signaling from the insulin receptor, Proc NatlAcad Sci US A,91 (1994) 4854.
7. Paul A T, Gohil V M & Bhutani K K, Modulating TNF-alpha signaling with natural products, Drug Discov Today, 11 (2006)725.
8. Oh J H & Kwon T K, Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells, Int Immunopharmacol, 9 (2009) 614.
9. Atal C K, Singh G B, Batra S, Sharma S & Gupta O P, Salai guggul ex-Boswellia serrata, a promising antihyperlipidemic and anti-arthritic agent, Indian JExp Biol, 12 (1980) 59.
10. Atal C K, Gupta O P & Singh G B, Salai guggul: A promising anti-arthritic and antihyperlipidemic agent, Br J Pharmacol, 74 (1981) 203.
11. Takada Y, Ichikawa H, Badmaev V & Aggarwal B B, Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression, J Immunol, 176 (2006) 3127.
12. Kim S, Choi J H, Kim J B, Nam S J, Yang J H, Kim J H & Lee J E, Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells, Molecules, 13(2008)2975.
13. Srimal R C, Khanna N M & Dhawan B N, A preliminary report on anti-inflammatory activity of curcumin, Indian J Med Res, 81(1971)215.
14. Chan M M, Inhibition of tumor necrosis factor by curcumin, a phytochemical, Biochem Pharmacol, 49 (1995) 1551.
15. Shishodia S & Aggarwal B B, Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis, JBiol Chem, 279 (2004) 47148.
16. Gupta O P, Ali M M, Ray Ghatak B J & Atal C K, Some pharmacological investigations of embelin and its semisynthetic derivatives, Indian J Physiol Pharmacol, 21 (1977)31.
17. Pillai N R & Santhakumari G, Anti-arthritic and anti-inflammatory actions of nimbidin, Planta Med, 43(1981)59.
18. Bose T K, Basu R K, Biswas B, De J N, Majumdar B C & Datta S, Cardiovascular effects of yellow oleander ingestion, J Indian MedAssoc, 97 (1999) 407.
19. Vakil R J, A clinical trial of Rauwolfia serpentina in essential hypertension, Br Heart J, 11 (1949) 350.
20. Bein H J, [Pharmacology of reserpin, a new alkaloid from Rauwolfia serpentina Benth.], Experientia, 9 (1953) 107.
21. Muller J M, Schlittler E & Bein H J, Reserpin, the sedative principle from Rauwolfia serpentina B, Experientia, 8 (1952) 338.
22. Sumitra M, Manikandan P, Kumar D A, Arutselvan N, Balakrishna K, Manohar B M & Puvanakrishnan R, Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status, Mol Cell Biochem, 224 (2001) 135.
23. Tandon J S, Dhar M M, Ramkumar S & Venkatesan K, Structure of coleonol, a bilogically active terpene from Coleus forskohlii, Indian J Chem, 15B (1977) 880.
24. Dubey M P, Srimal R C, Nityanand S & Dhawan B N, Pharmacological studies on coleonol, a hypotensive diterpene from Coleusforskohlii, JEthnopharmacol, 3 (1981) 1.
25. Krawinkel M B & Keding G B, Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia, Nutr Rev, 64 (2006)331.
26. Sugihara Y, Nojima H, Matsuda H, Murakami T, Yoshikawa M & Kimura I, Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice, JAsian Nat Prod Res, 2 (2000) 321.
27. Zhang Z, Jiang J, Yu P, Zeng X, Larrick J W & Wang Y, Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment,/Transl Med, 7 (2009) 62.
28. Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, Shibata H, Mitsunaga T, Hashimoto F & Kiso Y, Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro, JAgricFood Chem, 53 (2005) 4593.
29. Shin J E, Han M J, Song M C, Baek N I & Kim D H, 5-Hydroxy-7- (4'-hydroxy-3'-methoxyphenyl) - 1- phenyl- 3-heptanone: a pancreatic lipase inhibitor isolated from Alpinia officinarum, Biol Pharm Bull, 21 (2004) 138.
30. Shin J E, Joo Han M & Kim D H, 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase, Biol Pharm Bull, 26 (2003) 854.
31. Mehta V L, Malhotra C L & Kalrah N S, The effects of various fractions of gum guggul on experimentally produced hypercholesteramia in chicks, Indian J Physiol Pharmacol, 12 (1968)91.
32. Satyavati G V, Dwarkanath C & Tripathi S N, Experimental studies of the hypocholesterolemic effect of Commiphora mukul, Indian J Med Res, 57 (1969) 1950.
33. Bhutani K K, Birari R B & Kapat K, Potential anti-obesity and lipid lowering natural products: A Review, Natural Product Communications, 1 (2007) 331.
34. Birari R B & Bhutani K K, Pancreatic lipase inhibitors from natural sources: unexplored potential, Drug Discov Today, 12 (2007) 879.
35. Kunert O, Swamy R C, Kaiser M, Presser A, Buzzi S, Appa Rao A V N & Schuhly W, Antiplasmodial and leishmanicidal activity of biflavonoids from Indian Selaginella bryopteris, Phytochemistry Lett, 1 (2008) 171.
36. Rochanakij S, Thebtaranonth Y, Yenjai C & Yuthavong Y, Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture, Southeast Asian J Trop Med Public Health, 16 (1985) 66.
37. MacKinnon S, Durst T, Arnason J T, Angerhofer C, Pezzuto J, Sanchez-Vindas P E, Poveda L J & Gbeassor M, Antimalarial activity of tropical Meliaceae extracts and gedunin derivatives, J Nat Prod, 60 (1997) 336.
38. Bringmann G, Dreyer M, Michel M, Tayman F S & Brun R, Ancistroheynine B and two further 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus heyneanus Wall, Phytochemistry, 65 (2004) 2903.
39. Hazra B, Saha A K, Ray R, Roy D K, Sur P & Banerjee A, Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro, Trans R Soc Trop Med Hyg, 81 (1987)738.
40. Ray S, Hazra B, Mittra B, Das A & Majumder H K, Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani, Mol Pharmacol, 54 (1998) 994.
41. Croft S L, Evans AT & Neal R A, The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis, Ann Trop Med Parasitol, 79 (1985)651.
42. Ghosh A K, Bhattacharyya F K & Ghosh D K, Leishmania donovani: amastigote inhibition and mode of action of berberine, Exp Parasitol, 60 (1985) 404.
43. Kapil A, Piperine: a potent inhibitor of Leishmania donovani promastigotes in vitro, Planta Med, 59 (1993) 474.
44. Ray S, Majumder H K, Chakravarty A K, Mukhopadhyay S, Gil R R & Cordell G A, Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani, J Nat Prod, 59 (1996) 27.
45. Puri A, Saxena R P, Guru P Y, Kulshreshtha D K, Saxena K C & Dhawan B N, Immunostimulant Activity of Picroliv, the Iridoid Glycoside Fraction of Picrorhiza kurroa, and its Protective Action against Leishmania donovani Infection in Hamstersl, Planta Med, 58 (1992) 528.
46. Singh I P, Lai U R, Bodiwala H S, Mahajan R P & Bhutani K K. Anti-leishmanial Natural Products - A Review, In Recent Progress in Medicinal Plants, edited by (STUDIUM PRESS LLC, USA), 2006.
47. Hashimoto F, Kashiwada Y, Nonaka G, Nohara T, Cosentino L M & Lee K H, Evaluation of tea polyphenols as anti-HIV agents, Bioorg Med Chem Lett, 6 (1996) 695.
48. Kashiwada Y, Wang H K, Nagao T, Kitanaka S, Yasuda I, Fujioka T, Yamagishi T, Cosentino L M, Kozuka M, Okabe H, Ikeshiro Y, Hu C Q, Yeh E & LeeK H, Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids, J Nat Prod, 61 (1998) 1090.
49. Min B S, Jung H J, Lee J S, Kim Y H, Bok S H, Ma C M, Nakamura N, Hattori M & Bae K, Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease, Planta Med, 65 (1999) 374.
50. Ahn M J, Kim C Y, Lee J S, Kim T G, Kim S H, Lee C K, Lee B B, Shin C G, Huh H & Kim J, Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis, Planta Med, 68 (2002) 457.
51. Valsaraj R, Pushpangadan P, Smitt U W, Adsersen A, Christensen S B, Sittie A, Nyman U, Nielsen C & Olsen C E, New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica, J Nat Prod, 60 (1997) 739.
52. Singh I P, Bharate S B & Bhutani K K, Anti-HIV natural products, Curr Sci, 89 (2005) 269.
53. Prakash O, Bhakuni D S, Kapil R S, SubbaRao G S R & Ravindranath B, Diterpenoids of Roylea calycina (Roxb.) Briq,/Chem Soc Perkin Trans 1, (1979) 1305.
54. Pal R, Kulshreshtha D K & Rastogi R P, Antileukemic and other constituents of Tithonia tagitiflora Desf, J Pharm Sci, (1976)918.
55. Kaur G, Stetler-Stevenson M, Sebers S, Worland P, Sedlacek H, Myers C, Czech J, Naik R & Sausville E, Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275, J Natl Cancer Inst, 84 (1992) 1736.
56. Sedlacek H H, Mechanisms of action of flavopiridol, Crit Rev Oncol Hematol, 38 (2001) 139.
57. Pettit G R, Singh S B, Hamel E, Lin C M, Alberts D S & Garcia-Kendall D, Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4, Experientia, 45(1989)209.
58. Sarin J P S, Singh S, Garg H S, Khanna N M & Dhar M M, A flavonol glycoside with anticancer activity from Tephrosia Candida, Phytochemistry, 15 (1976) 232.
59. Mohana K, Purushothaman K K & Susan T, Drug potential of echitamine chloride in cancer chemotherapy, Bull Med Ethnobot Res, 6(1985) 124.
60. Rao K V. Alkaloids of Tylophora indica and T. delzelli. U.S. Patent 3,497,593, Feb. 24, 1970.
61. Narasimhan T R, Harindranath N, Premlata S, Murthy B S & Rao P V, Toxicity of the sesquiterpene lactone parthenin to cultured bovine kidney cells, Planta Med, (1985) 194.
62. Vaidya V G, Kulkarni I & Nagasampagi B A, In vitro and in vivo cytogenic effects of sesquiterpene lactone, parthenin, derived from Parthenium hysterophorus, Indian J Exp Biol, 16(1978)1117.
63. Raghavendra T R, Vaidyanathan N P, Swathi H K, Ramesha B T, Ravikanth G, Ganeshaiah K N, Srikrishna A & Shaanker U A, Prospecting for alternate sources of shikimic acid, a precursor of Tamiflu, a bird-flu drug, Curr Sci, 96 (2009) 771.
64. Atal C K, Dubey R K & Singh J, Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism, J Pharmacol Exp Ther, 232 (1985) 258.
65. Geuns J M, Stevioside, Phytochemistry, 64 (2003) 913.